Post-translational modifications of histones, in general, and acetylation/deacetylation, in particular, can dramatically alter gene expression in eukaryotic cells. In humans, four highly homologous class I HDAC enzymes (HDAC1, HDAC2, HDAC3, and HDAC8) have been identified to date. Although HDAC3 shares some structural and functional similarities with other class I HDACs, it exists in multisubunit complexes separate and different from other known HDAC complexes, implying that individual HDACs might function in a distinct manner. In this current study, to understand further the cellular function of HDAC3 and to uncover possible unique roles this protein may have in gene regulation, we performed a detailed analysis of HDAC3 using deletion mutations. Surprisingly, we found that the non-conserved C-terminal region of HDAC3 is required for both deacetylase and transcriptional repression activity. In addition, we discovered that the central portion of the HDAC3 protein possesses a nuclear export signal, whereas the C-terminal part of HDAC3 contributes to the protein's localization in the nucleus. Finally, we found that HDAC3 forms oligomers in vitro and in vivo and that the N-terminal portion of HDAC3 is necessary for this property. These data indicate that HDAC3 comprises separate, non-overlapping domains that contribute to the unique properties and function of this protein.
Post-translational modification of nucleosomal histones can convert regions of chromosomes into transcriptionally active or inactive chromatin. The best understood post-translational modification of histones is the acetylation of ⑀-amino groups on conserved lysine residues in the histones' N-terminal tail domains. In addition to its effect on transcription, acetylation of core histones has been correlated with many important cellular processes, including chromatin assembly, DNA repair, and recombination (1) (2) (3) (4) (5) (6) (7) .
In general, the status of histone acetylation in a cell is regulated by histone acetyltransferases and histone deacetylases (HDACs). 1 In humans, HDACs are divided into three categories (8 -11) : the class I RPD3-like proteins (HDAC1, HDAC2, HDAC3, and HDAC8); the class II HDA1-like proteins (HDAC4, HDAC5, HDAC6, HDAC7, HDAC9, and HDAC10); and the class III SIR2-like proteins. The recent availability of the human genome sequence revealed the possibility of additional HDACs whose class assignment has yet to be determined (12) . Because class I HDACs are ubiquitously expressed, whereas most class II HDACs are tissue-specific, it has been proposed that the class I enzymes may be important in the regulation of housekeeping genes (13, 14) . By far, the most thoroughly studied human HDACs are the two founding members of the class I enzymes, HDAC1 and the closely related HDAC2 protein. HDAC1 and HDAC2 exist together in at least three distinct multiprotein complexes called the Sin3, the NuRD/NRD/Mi2, and the CoREST complexes (15) (16) (17) (18) (19) (20) (21) (22) . In addition, many transcription factors interact directly with HDAC1/2 and thus may target HDAC1/2 to specific promoters (8, 23) . Because of the high degree of sequence similarity between HDAC1 and HDAC2, together with the fact that they often coexist in the same complexes, it is difficult to assess the functional differences between these two enzymes.
Human HDAC3 was first cloned based on sequence similarities to HDAC1 and HDAC2 (13, 24, 25) . Analysis of the predicted amino acid sequence of HDAC3 revealed an open reading frame of 428 amino acids with a predicted molecular mass of 49 kDa. The HDAC3 protein is 50% identical in DNA sequence and 53% identical in protein sequence compared with the previously cloned human HDAC1. Comparison of the HDAC3 sequence with human HDAC2 also yielded similar results, with 51% identity in DNA sequence and 52% identity in protein sequence.
Unlike HDAC1/2, HDAC3 is present in a unique large protein complex that contains members of the nuclear receptor corepressor family and the transducin ␤-like I protein, whose gene is mutated in human sensorineural deafness (26 -30) . Also, unlike HDAC1 or HDAC2, HDAC3 is essential for DT40 cell viability and is localized in both the nuclei and cytoplasm of DT40 cells (31) . Therefore, it appears that some functions of HDAC3 may be distinct from HDAC1 and HDAC2 and possibly all other HDACs.
Early studies indicate that HDAC3 mRNA is up-regulated in PHA-activated T cells and down-regulated by granulocyte macrophage-colony-stimulating factor (25) . Furthermore, overexpression of HDAC3 in transfected THP-1 or HeLa cells leads to an accumulation of cells in G 2 /M phase, with an increase in cell size and aberrant nuclear morphology (25) . The significance of these observations is not clear at this time. The mouse HDAC3 gene is located on chromosome 18B3, and the human HDAC3 gene localizes to a syntenic region in chromosome 5q31 (32) (33) (34) (35) .
To facilitate the functional studies of HDAC3 and possibly identify novel structural-functional motifs, we constructed a series of HDAC3 deletion mutants and assayed for 1) their abilities to deacetylate core histones, 2) their abilities to repress transcription, 3) their nuclear/cytoplasmic localization, and 4) their abilities to oligomerize. Our results indicate that different activities reside in independent, non-overlapping domains within HDAC3.
EXPERIMENTAL PROCEDURES
Plasmids-FLAG-HDAC3 serial deletion mutants were made by digesting the HDAC3 cDNA using appropriate restriction enzyme sites to generate the deletion mutants, which were then fused in-frame into the pME18S-FLAG or pCEP4F vector (13) . The FLAG-HDAC3 serial deletion mutant insertion fragments were subsequently subcloned into the Gal4 expression plasmid pM1, which contains a nuclear localization signal (NLS) (36) . Gal4-HDAC3 point mutants were constructed by using adapter oligonucleotides. GFP-HDAC1, GFP-HDAC2, and GFP-HDAC3 were constructed by inserting the HDAC1, HDAC2, or HDAC3 cDNA in-frame into the vector pEGFP-C3 (CLONTECH). HDAC3-GFP was made by inserting the HDAC3 cDNA in-frame into the pEGFP-N2 vector (CLONTECH), where the stop codon was eliminated by PCR. GFP-HDAC3 deletion mutants were made by digesting the HDAC3 cDNA with appropriate restriction enzymes and subsequently cloning the restriction fragments into pEGFP-C3. HA-hCRM1 was constructed by subcloning the human cDNA of CRM1 (37) into a modified pcDNA3.1 (Invitrogen) vector, which contains an HA epitope. FLAG-HDAC1, FLAG-HDAC2, and FLAG-HDAC3 have been described previously (13) . Mammalian expression plasmid GST-HDAC3 was made by subcloning the human HDAC3 cDNA into the mammalian GST expression vector pCMV-GST (38) . Bacterial expression plasmids GST-HDAC3, GST-HDAC2, GST-HDAC8, and GST-NCoR-(1-293) have been described (13, 26, 39) . Human cDNAs for TAFII55 and TBP were subcloned into GST expression vectors pGSTag (40) and pGEX-4T-3 (Amersham Biosciences, Inc.), respectively. HA-HDAC3 was made by subcloning the human HDAC3 cDNA into a modified pcDNA3.1 vector, described above. All constructs were confirmed by DNA sequencing analysis.
Histone Deacetylase Assays-Deacetylase activity was determined using hyperacetylated core histones purified from HeLa cells, as described (41), with incubation overnight at room temperature.
Cell Culture and Transfections-HeLa and 293 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 IU/ml penicillin, and 100 g/ml streptomycin (Invitrogen). For transfections, 5 g of an effector plasmid and, in some cases, 5 g of a Gal4 luciferase reporter plasmid were introduced into cells by calcium phosphate precipitation (42) . Cells were harvested 48 h after transfection for further analysis.
Luciferase Assays-Luciferase activity was determined using the dual-luciferase assay system (Promega).
Immunoprecipitation-Anti-FLAG, anti-HA, and anti-Gal4 antibodies were obtained from Sigma Chemical Co., BAbCO, and Santa Cruz Biotechnology, respectively. Immunoprecipitations were performed under low stringency conditions, as described previously (16) , using whole cell extracts derived from HeLa or 293 cells transfected with different plasmids. Immunoprecipitated proteins were resolved by electrophoresis using 10% SDS-PAGE and transferred to polyvinylidene difluoride membranes, and membranes were probed with the indicated antibodies. In some experiments, deacetylase activity assays were performed using the immunoprecipitated products.
Fluorescence Microscopy-293 cells were grown on charged slides inside 100-mm tissue culture plates for 24 h and then transfected with 5 g each of plasmids expressing various GFP fusion proteins. Two days later, cells were washed with ice-cold phosphate-buffered saline, fixed with 4% paraformaldehyde for 10 min, rinsed again with phosphatebuffered saline, and dried. Coverslips were applied with one drop of anti-fade mounting medium with 4Ј,6-diamidino-2-phenyl-indole (Vector) before analysis under a fluorescence microscope.
GST Pull-down Assay-GST and GST fusion proteins were expressed and purified as described previously (40) . 35 S-Labeled HDAC3 protein was prepared from pGEM7Zf-HDAC3 using T7 RNA polymerase and the coupled transcription-translation rabbit reticulocyte lysate system (Promega). Equal molar quantities of either GST or GST fusion proteins on glutathione-Sepharose beads were incubated with labeled proteins. Binding reactions, washing conditions, and analyses by electrophoresis followed by autoradiography were done exactly as described (40) .
Chemical Cross-linking-Chemical cross-linking using bis(sulfosuccinimidyl) (BS 3 ) were performed essentially as described (43) . Each reaction was performed at room temperature in buffer containing 25 mM HEPES (pH 7.3), 200 mM NaCl, 0.5 mM EDTA, 0.5 mM dithiothreitol, 0.01% Nonidet P-40, and 20% glycerol. The reactions were terminated by addition of 100 mM glycine.
RESULTS

The Unique Extreme C Terminus of HDAC3 Is Required for
Histone Deacetylase and Transcriptional Repression Activities-A series of plasmids that express different portions of the HDAC3 protein fused to FLAG epitope tags were used to identify the domains on HDAC3 necessary for its histone deacetylase activity. Anti-FLAG immunoprecipitates prepared from lysates of transfected HeLa cells were used for histone deacetylase assays. As shown in Fig. 1 (A and F) , a full-length HDAC3 possesses histone deacetylase enzymatic activity, whereas a mutant that lacks the last 27 residues of HDAC3-(1-401) had a significantly lower activity. Further C-terminal deletions of HDAC3 reduced activity to background levels. These results suggest that the extreme C-terminal of HDAC3 is required for full deacetylase activity. In four independent experiments, all fusion proteins could be detected by Western blots using a monoclonal antibody specific for the FLAG epitope (Fig. 1B) , ruling out the possibility that the truncated fusion proteins failed to deacetylate histones, because they were unstable and failed to accumulate within transfected cells.
We have previously shown that HDAC3 can repress transcription when bound upstream of a basal promoter (13) . To determine if the region of HDAC3 that is necessary for deacetylase enzymatic activity correlates with a domain responsible for repression, we prepared plasmids that express Gal4-HDAC3 fusion proteins. To assay for repression, HeLa cells were cotransfected with these plasmids and a luciferase reporter plasmid containing Gal4-DNA binding sites upstream of a minimal thymidine kinase promoter. Results from several independent experiments were averaged and are presented in Fig. 1 (C and F) . Whereas full-length HDAC3 (pGal4-HDAC3-(1-428)) repressed transcription efficiently, 1-401 and all other C-terminal deletion mutants did not. The Gal4 fusion proteins were expressed and active as determined by Western blots and by deacetylase assays (Fig. 1, D and E; data not shown). Thus, the portion of HDAC3 that is important for histone deacetylase enzymatic activity (consisting of at least amino acids 401-428) overlaps with the region that is critical for transcriptional repression. This correlation supports the view that histone deacetylation by HDAC3 is closely linked to transcriptional repression.
To further analyze the contribution of the C-terminal of HDAC3 to repression and deacetylation, we prepared three HDAC3 point mutants with one to three amino acid substitutions in this critical area. As shown in Fig. 1 (C and D) , although a deletion of residues 401-428 of HDAC3 severely compromised its transcriptional and enzymatic activities, the particular point mutations we made in this region did not result in similar effects.
Subcellular Localization of HDAC3 Is Regulated by Competing Nuclear Import and Export Signals-Unlike HDAC1 and HDAC2, which are located exclusively in the nucleus (44, 45; Fig. 2A ), immunofluorescence studies using anti-HDAC3 antiserum revealed that HDAC3 is located in both the nucleus and cytoplasm of DT40 cells (31) . A similar subcellular distribution was observed using an antibody against the FLAG epitope in COS cells transfected with an expression plasmid encoding FLAG-tagged HDAC3 (46) . To rule out the possibility that the previous findings resulted from antibody cross-reactivity or an artifact generated by the FLAG epitope, we expressed HDAC3 fused to the green fluorescence protein (GFP) in 293 cells and determined the protein's localization by fluorescence microscopy. As shown in Fig. 2 (A and C) , N-terminally GFP-fused HDAC3 (GFP-HDAC3) and C-terminally GFP-fused HDAC3 (HDAC3-GFP) were present both in the nucleus and cytoplasm of 293 cells, thus confirming previous findings.
N-terminal deletion analysis of HDAC3 revealed that the subcellular localization of GFP-HDAC3-(122-428) and GFP-HDAC3-(180 -428) was identical to wild-type HDAC3 suggesting that the first 180 residues of HDAC3 do not have a role in HDAC localization. In contrast, a C-terminal deletion mutant, GFP-HDAC3-(1-313), showed that the last 116 residues of HDAC3 are crucial for nuclear localization of the HDAC3 protein. This is confirmed by the observation that GFP-HDAC3-(180 -313) is predominantly cytoplasmic and is consistent with the finding that 313-428 is sufficient to direct cytoplasmically located GFP into the nucleus.
Residues 180 -313 of HDAC3 Contain a Nuclear Export Signal (NES)-To determine if the cytoplasmic location of HDAC3 is due to an inhibition of nuclear import or the presence of a nuclear export mechanism, we transfected 293 cells with plasmids that express different GFP-HDAC3 fusion proteins and treated the cells with Leptomycin B (LMB), an inhibitor of the CRM1/exportin1-related export pathway (47, 48) . As shown in Fig. 2 (A and C) , LMB treatment caused GFP-HDAC3, HDAC3-GFP, GFP-HDAC3-(122-428), GFP-HDAC3-(180 -428), GFP-HDAC3-(1-313), and GFP-HDAC3-(180 -313) to redistribute entirely into the nucleus, indicating that, in addition to its nuclear localization sequences, HDAC3 contains an NES located in residues 180 -313.
To determine if HDAC3 interacts with human CRM1 (hCRM1), a cellular export factor for proteins with leucine-rich NESs (37, 47, 49 -54) , we cotransfected 293 cells with plasmids that express HA-tagged hCRM1 and FLAG-tagged HDAC3.
Immunoprecipitation with anti-FLAG antibody followed by immunoblotting with anti-HA revealed that hCRM1 coprecipitates with HDAC3 (Fig. 2B, lane 1) . The HDAC3-hCRM1 interaction is specific, because an unrelated protein, FKBP25, fused to FLAG, did not coprecipitate with hCRM1 (lane 9). Furthermore, fragments of HDAC3 that contain the putative NES (1-401, 1-373, 1-313, 122-428) coprecipitate with hCRM1 but not fragments that do not contain this sequence (1-265, 1-180, 1-122). A fragment of HDAC3 containing 180 -313 alone specifically coprecipitates with hCRM1 (lane 10). Collectively, our data support the idea that the subcellular localization of HDAC3 is regulated at least in part by a CRM1/ exportin 1-related export pathway. HDAC3 Proteins Self-associate through Their N-terminal Region-During our structure-function analysis of HDAC3, we consistently found that epitope-tagged HDAC3 coprecipitates with the cellular endogenous HDAC3 protein, suggesting that the protein very likely forms oligomers in vivo. Specifically, immunoprecipitates of an extract prepared from cells that express FLAG-HDAC3, but not extracts from cells that express FLAG-HDAC1 or FLAG-HDAC2, as detected by immunoblotting with an anti-HDAC3 antibody, contained two bands that correspond to the molecular masses of FLAG-HDAC3 and HDAC3 (Fig. 3A, compare lane 1 with lanes 2 and 3) . Similarly, GST-HDAC3 coprecipitates with FLAG-HDAC3 in cells that express both proteins (Fig. 3B, compare lanes 1 and 3) . The anti-FLAG antibody used in this experiment did not cross-react with GST-HDAC3 (lane 2).
To confirm a physical self-association of HDAC3, we employed a GST affinity matrix to capture the HDAC3 protein. Bacterially expressed GST or GST fusion proteins were bound to glutathione-Sepharose beads and incubated with 35 S-labeled HDAC3 produced by in vitro translation in a reticulocyte lysate. The beads were washed, boiled in sample buffer, and analyzed by SDS-PAGE. As shown in Fig. 3C , GST-HDAC3, but not GST alone, clearly bound HDAC3 (compare lanes 1 with 4) . Consistent with earlier studies (26) GST-NCoR interacted with HDAC3 (lane 8). Importantly, GST-TFIIB, GST-TAFII55, GST-HDAC2, and GST-HDAC8 did not bind HDAC3 in this assay, confirming the specificity of the HDAC3-HDAC3 interaction (lanes 2, 3, 6, 7 ).
To perform a detailed mapping of the HDAC3 domain that is required for association, we expressed different fragments of HDAC3 fused to the FLAG epitope in HeLa cells together with an HA-tagged HDAC3. Association was assessed by immunoprecipitation with anti-FLAG antibody followed by immunoblotting with anti-HA. As shown in Fig. 4A , five C-terminally truncated FLAG-HDAC3 mutants (fragments 1-401, 1-373, 1-313, 1-265, and 1-180) but not an N-terminal deletion mutant (fragment 180 -428), bound HA-HDAC3 (lanes 5-11) , suggesting that the HDAC3 self-association domain is located between residues 1-180 of HDAC3. Further analysis revealed that a smaller deletion mutant (fragment 1-122) can still bind HA-HDAC3 (lane 3), whereas FLAG-HDAC3-(122-428) completely lost its ability to interact with HA-HDAC3 (lane 4), suggesting that the self-association domain in HDAC3 is located between residues 1-122 (Fig. 4B) . In fact, a very low expression of FLAG-HDAC3-(1-122) was sufficient for interaction with HA-HDAC3 (Fig. 4A, bottom panel, lane 3) . 
HDAC3 Can Form Dimers and Trimers-
To determine the nature of the complexes formed by HDAC3, we performed chemical cross-linking studies with in vitro translated HDAC3 proteins. The predicted molecular mass of HDAC3 and the apparent subunit molecular mass determined by SDS-PAGE are both 49 kDa (Fig. 5, lane 1) . After treatment with the cross-linking reagent BS 3 , two major cross-linked species of HDAC3 were detected that had apparent masses of ϳ100 and 150 kDa on SDS-PAGE (lane 2). The amount of oligomer species increased in response to increasing duration of BS 3 treatment (lanes 3-8) , and because the major cross-linked products are roughly two and three times the subunit molecular mass, these data suggest that HDAC3 forms homodimers and homotrimers in vivo.
DISCUSSION
In this report, we have localized the sequences in HDAC3 responsible for deacetylase activity, transcriptional repression, subcellular localization, and oligomerization. One of the most striking common features of the class I HDACs is that all members of this class possess a highly conserved region located in the central portion of each protein (13, 40, 55-57 ). There are several distinctions that exist, however, among the various class I members. For HDAC3, the most noticeable is the lack of a region corresponding to the N-terminal segments of HDAC1, HDAC2, and HDAC8. HDAC3 also lacks a region that corresponds to the C-terminal segments of HDAC1 and HDAC2. In addition, within HDAC3, the last 44 residues are quite different from those of other HDACs, and computer analysis of this C-terminal region of HDAC3 does not reveal similarity to any known proteins. A straightforward prediction from these data would be that the extreme C-terminal of HDAC3 is dispensable for deacetylase and transcriptional repression activity. Our findings here, that the last 27 residues of HDAC3 are required for deacetylation of core histones and for repression of transcription, are quite unexpected. It is possible that the catalytic domain of HDAC3 is located in its conserved region and that deletion of the extreme C-terminal of HDAC3 changes the global conformation of the protein and renders it inactive. The attractiveness of this model is reinforced by our finding that several point mutations in the C-terminal of HDAC3 did not have any effect on the protein's transcriptional and deacetylation activities. Whatever the case, consistent with the hypothesis that, when HDAC3 is targeted to promoters, at least one of its mechanisms of repression is deacetylation of histones, mutants of HDAC3 that no longer possess deacetylase enzymatic activity also do not repress transcription.
FIG. 2-continued
Structure-Function Analysis of HDAC3
One of the unusual characteristics of HDAC3 is its subcellular localization. Although one group claims that, similar to other class I HDACs, HDAC3 is predominantly a nuclear protein (24, 58), we and others have found, using a variety of different methods, that HDAC3 appears to be located both in the nucleus and the cytoplasm. Perhaps this could be a reflection of the different cell types used by different laboratories. A sequence present at position 29 -41 of HDAC3 (LALTHSLVL-HYGL) that resembles the canonical NES (⌿n⌿XX⌿X⌿, where ⌿ indicates hydrophobic residues and X indicates any amino acid) has been assumed to function as the NES for HDAC3 (31) . Our deletion analysis, however, indicates that the NES resides within residues 180 -313 of HDAC3 and that this sequence is necessary and sufficient for binding to CRM1.
Although there is no dispute that the leucine-rich NES is a highly conserved sequence used by a number of proteins to facilitate their delivery from the nucleus to the cytoplasm (59, 60) , the exact role of the NES for interaction with CRM1 is controversial. Many studies demonstrated that alteration of the leucine-rich NES abolished the binding of the NES-containing substrate to CRM1 (37, 49, 51, 61, 62) . In contrast, at least two reports exist in which binding of CRM1 to NES-containing substrates is shown to be independent of the NES (63, 64) . Here, our data clearly indicate that CRM1 binds HDAC3, not through the putative NES in the N-terminal of HDAC3 (residues 29 -41) but rather through sequences located in the central part (residues 180 -313) of the protein. In HDAC1 and HDAC2, the regions that correspond to residues 181-333 of HDAC3 are very similar to each other (93% identity). However, comparison of 181-333 of HDAC3 to the corresponding region in either HDAC1 or HDAC2 yielded only ϳ68% identity. Our results from experiments with the antibiotic LMB suggest that the presence of the cytoplasmic fraction of HDAC3 is due to the activity of an NES located in residues 180 -313 that uses the CRM1 export pathway. Although at this time we cannot rule out the possibility that the 180 -313 region of HDAC3 interacts with another NES-containing protein, further mapping studies of HDAC3 based on the data gathered already should allow us to obtain a clear picture of the exact export mechanism for this protein.
In addition to its NES, HDAC3 contains a nuclear localization sequence (NLS) in its C terminus (residues 313-428). This domain of HDAC3 is sufficient for the transport of a reporter fusion protein into the nucleus. However, unlike HDAC1 and HDAC2, whose nuclear localization is also dependent on their C-terminal domains, HDAC3 does not contain a lysine-rich motif within its C terminus. In future work, therefore, it will be important to determine the exact sequence in HDAC3 that replaces the function of the lysine-rich nuclear localization signal motif. Because HDAC3 possesses both an NES and an NLS, we suggest that the balance between these two elements dictates HDAC3's subcellular localization. Perhaps this balance is sensitive to the overall structure of HDAC3, or it might be cell type-specific or signal-dependent.
Regulated nuclear localization has been described for the class II HDACs. Increasing evidence suggests that the subcellular compartmentalization of class II HDACs is tightly regulated by several different signaling pathways. For example, the 14-3-3 proteins negatively regulate the actions of HDAC4 by excluding it from the nucleus (65, 66) , and calcium/calmodulindependent protein kinase signaling induces nuclear export of HDAC4 and HDAC5 by phosphorylation of these two proteins (46) . In contrast, activation of the Ras-MAPK pathway by expression of Ras or constitutively active MAPK/ERK kinase 1 increases the nuclear:cytoplasmic ratio of HDAC4 in C2C12 cells (67) . Work is now underway to determine if the subcellular distribution of HDAC3 is regulated by these or other signaling pathways.
Early studies have demonstrated that HDAC1 associates with HDAC2, suggesting that at least two catalytic subunits may be required to form an active enzymatic complex in vivo (68) . Using an overexpression system coupled with immunoprecipitation, it was shown that HDAC3 can coprecipitate with HDAC4, HDAC5, and HDAC7 (14, 58) . We have found that endogenous HDAC3 associates with itself and only a very small fraction of endogenous HDAC3 interacts with HDAC4 in vivo (data not shown). By overexpression of epitope-tagged HDAC3 and immunoprecipitation or by GST pull-down methods, we have found that HDAC3 binds efficiently to itself. Using in vitro translated proteins in solution at relatively low concentrations, we also demonstrate that HDAC3 exists as a dimer or a trimer that can be detected by chemical cross-linking. Interestingly, the region of HDAC3 required for oligomerization was mapped to the N-terminal first 122 residues of HDAC3, a region that is essential for cell viability (31) . Recent studies suggest that like HDAC3, HDAC1 also associates with itself via its N-terminal domain (69) . However, unlike HDAC1, HDAC3 mutants lacking histone deacetylase activity, but nevertheless containing the oligomerization domain, cannot recruit wildtype HDAC3 to deacetylate histones or to repress transcription. Thus, we suggest that, although oligomerization may be a common feature of HDAC proteins, the nature and consequences of oligomerization may differ for different members of the HDAC family.
In summary, our results demonstrate that HDAC3 has a modular design and is composed of distinct domains involved in histone deacetylation, transcriptional repression, subcellular localization, and oligomerization. The HDAC3 mutants generated in this study will serve as useful tools in our continued effort to elucidate further how histone deacetylation regulates gene expression.
